Manufacturer record
Bayberry Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Bayberry Pharmaceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between May 2020 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Bayberry Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Itraconazole Capsule | BBC25I02AMfg 2025-12 · Exp 2027-11 | MisbrandadMisbranded | SDTL, ChhattisgarhState lab | May 2026 |
| Atorfirst-10 (Atorvastatin Tablets IP 10 mg) | BT-0364Mfg 2019-07 · Exp 2021-06 | DissolutionDissolution | CDTL MumbaiCDSCO lab | May 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.